Log In
Print this Print this

F-AV-133 (formerly AV-133)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionF-18-labeled PET imaging agent that targets vesicular monoamine transporter 2 (VMAT2)
Molecular Target Vesicular monoamine transporter 2 (VMAT2) (SLC18A2)
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase II
Standard IndicationRadiologic imaging
Indication DetailsDiagnose diabetes; Diagnose neurodegenerative diseases; Diagnose Parkinson's disease (PD) and dementia with Lewy bodies (DLB)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today